CGFAX
Price
$83.30
Change
+$0.96 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
WPASX
Price
$48.68
Change
+$0.88 (+1.84%)
Updated
Jul 31 closing price
Net Assets
461.2M
Interact to see
Advertisement

CGFAX vs WPASX

CGFAX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
CGFAX vs. WPASX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGFAX is a StrongBuy and WPASX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGFAX has more cash in the bank: 357B vs. WPASX (461M). CGFAX pays higher dividends than WPASX: CGFAX (0.24) vs WPASX (0.00). CGFAX was incepted earlier than WPASX: CGFAX (24 years) vs WPASX (12 years). WPASX (1.00) is less costly to investors than CGFAX (0.62). CGFAX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). WPASX initial investment is less costly to investors than CGFAX (4%) vs CGFAX (4%). CGFAX has a lower initial minimum investment than WPASX: CGFAX (250) vs WPASX (2500). CGFAX annual gain was more profitable for investors over the last year : 1.42 vs. WPASX (-12.18). CGFAX return over 5 years is better than : 13.19 vs. WPASX (-19.18).
CGFAXWPASXCGFAX / WPASX
Total Expense Ratio0.621.0062%
Annual Report Gross Expense Ratio0.621.0062%
Fund Existence24 years12 years-
Gain YTD5.590-2.523-222%
Front Load4%4%82%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets357B461M77,440%
Annual Yield % from dividends0.240.00-
Returns for 1 year1.42-12.18-12%
Returns for 3 years35.41-1.02-3,479%
Returns for 5 years13.19-19.18-69%
Returns for 10 years103.5976.05136%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEAM101.012.89
+2.95%
Atlassian Corp
SLQT0.750.02
+2.81%
SelectQuote
OGG2.390.01
+0.42%
Osisko Gold Group Inc
IMNN1.59-0.01
-0.62%
Imunon Inc
DNLI23.02-1.33
-5.46%
Denali Therapeutics